A retrospective, cohort study assessing safety of Ticagrelor compared to Clopidogrel in treating coronary heart disease patients after percutaneous coronary intervention.
Phase of Trial: Phase IV
Latest Information Update: 21 Jan 2017
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Therapeutic Use
- 21 Jan 2017 Status changed from not stated to completed.
- 08 Nov 2016 New trial record.